- Home
- PBHC vs RENB Comparison
PBHC vs RENB Comparison
Compare PBHC & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBHC
- RENB
- Stock Information
- Founded
- PBHC 1859
- RENB 2011
- Country
- PBHC United States
- RENB United States
- Employees
- PBHC N/A
- RENB N/A
- Industry
- PBHC Major Banks
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- PBHC Finance
- RENB Health Care
- Exchange
- PBHC Nasdaq
- RENB Nasdaq
- Market Cap
- PBHC 108.9M
- RENB 121.3M
- IPO Year
- PBHC N/A
- RENB N/A
- Fundamental
- Price
- PBHC $16.44
- RENB $0.71
- Analyst Decision
- PBHC
- RENB
- Analyst Count
- PBHC 0
- RENB 0
- Target Price
- PBHC N/A
- RENB N/A
- AVG Volume (30 Days)
- PBHC 9.4K
- RENB 1.8M
- Earning Date
- PBHC 01-30-2025
- RENB 02-12-2025
- Dividend Yield
- PBHC 2.40%
- RENB N/A
- EPS Growth
- PBHC N/A
- RENB N/A
- EPS
- PBHC 0.25
- RENB N/A
- Revenue
- PBHC $35,494,000.00
- RENB N/A
- Revenue This Year
- PBHC N/A
- RENB N/A
- Revenue Next Year
- PBHC N/A
- RENB N/A
- P/E Ratio
- PBHC $65.83
- RENB N/A
- Revenue Growth
- PBHC N/A
- RENB N/A
- 52 Week Low
- PBHC $11.41
- RENB $0.40
- 52 Week High
- PBHC $19.86
- RENB $5.25
- Technical
- Relative Strength Index (RSI)
- PBHC 44.90
- RENB 39.34
- Support Level
- PBHC $15.37
- RENB $0.70
- Resistance Level
- PBHC $16.52
- RENB $0.94
- Average True Range (ATR)
- PBHC 0.44
- RENB 0.14
- MACD
- PBHC -0.06
- RENB -0.03
- Stochastic Oscillator
- PBHC 47.98
- RENB 2.57
About PBHC Pathfinder Bancorp Inc. (MD)
Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.